| 商品名称 | Velactis |
|---|---|
| 适用类别 | Veterinary |
| 治疗领域 | |
| 通用名/非专利名称 | cabergoline |
| 活性成分 | cabergoline |
| 产品号 | EMEA/V/C/003739 |
| 患者安全信息 | No |
| 许可状态 | Withdrawn |
| ATC编码 | QG02CB03 |
| 是否额外监管 | No |
| 是否仿制药或hybrid药物 | No |
| 是否生物类似药 | No |
| 是否附条件批准 | No |
| 是否特殊情形 | No |
| 是否加速审评 | No |
| 是否罕用药 | No |
| 上市许可日期 | 2015/12/09 |
| 上市许可开发者/申请人/持有人 | Ceva Santé Animale |
| 人用药物治疗学分组 | |
| 兽用药物治疗学分组 | Genito urinary system and sex hormones;Other gynecologicals;Prolactine inhibitors |
| 欧盟委员会决定日期 | 2020/12/11 |
| 修订号 | 1 |
| 治疗适应症 | For use in the herd management programme of dairy cows as an aid in the abrupt drying-off by reducing milk production to: reduce milk leakage at drying off; reduce the risk of new intramammary infections during the dry period; reduce discomfort. |
| 适用物种 | |
| 兽用药物ATC编码 | QG02CB03 |
| 首次发布日期 | 2016/08/22 |
| 最后更新日期 | 2021/01/25 |
| 产品说明书 | https://www.ema.europa.eu/en/documents/product-information/velactis-epar-product-information_en.pdf |
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/veterinary/EPAR/velactis |